An update on the validity of irisin assays and the link between irisin and hepatic metabolism

Metabolism: Clinical and Experimental

Volumn 64, Issue 9, 2015, Pages 937-942

  Polyzos, Stergios A ^a   Mantzoros, Christos S ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRISIN; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3; PHOSPHOLIPASE; UNCLASSIFIED DRUG; FIBRONECTIN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ARTICLE; CROSS REACTION; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL STUDY; HUMAN; LIPOGENESIS; LIVER METABOLISM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; WESTERN BLOTTING; BLOOD; CAUCASIAN; FEMALE; GENETICS; MALE;

EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRONECTINS; HUMANS; LIPASE; MALE; MEMBRANE PROTEINS;

EID: 84939569154     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.06.005     Document Type: Editorial

References (46)

1. J.N. Hirschhorn, and Z.K. Gajdos Genome-wide association studies: Results from the first few years and potential implications for clinical medicine Annu Rev Med 62 2011 11 24
2. Q.M. Anstee, and C.P. Day The genetics of NAFLD Nat Rev Gastroenterol Hepatol 10 2013 645 655
3. S.A. Polyzos, J. Kountouras, C. Zavos, and G. Deretzi Nonalcoholic fatty liver disease: Multimodal treatment options for a pathogenetically multiple-hit disease J Clin Gastroenterol 46 2012 272 284
4. P. Bostrom, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, and et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 481 2012 463 468
5. F. Villarroya Irisin, turning up the heat Cell Metab 15 2012 277 278
6. S.A. Polyzos, J. Kountouras, K. Shields, and C.S. Mantzoros Irisin: A renaissance in metabolism? Metabolism 62 2013 1037 1044
7. A. Viitasalo, M. Atalay, J. Pihlajamaki, J. Jaaskelainen, A. Korkmaz, D. Kaminska, and et al. The 148M allele of the PNPLA3 gene is associated with plasma irisin levels in a population sample of Caucasian children: The PANIC Study Metabolism 64 2015 793 796
8. S.A. Polyzos, and C.S. Mantzoros Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease Metabolism 63 2014 161 167
9. S. Sookoian, and C.J. Pirola Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease Hepatology 53 2011 1883 1894
10. L. Valenti, A. Al-Serri, A.K. Daly, E. Galmozzi, R. Rametta, P. Dongiovanni, and et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1209 1217
11. Y. Rotman, C. Koh, J.M. Zmuda, D.E. Kleiner, and T.J. Liang The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease Hepatology 52 2010 894 903
12. L. Zhang, W. You, H. Zhang, R. Peng, A. Yao, X. Li, and et al. PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: A meta-analysis J Gastroenterol Hepatol 30 2015 821 829
13. A.G. Singal, H. Manjunath, A.C. Yopp, M.S. Beg, J.A. Marrero, P. Gopal, and et al. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: A meta-analysis Am J Gastroenterol 109 2014 325 334
14. M.M. Hassan, A. Kaseb, C.J. Etzel, H. El-Serag, M.R. Spitz, P. Chang, and et al. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction Mol Carcinog 52 Suppl. 1 2013 E139 E147
15. L. Valenti, M. Rumi, E. Galmozzi, A. Aghemo, M.B. Del, N.S. De, and et al. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C Hepatology 53 2011 791 799
16. J.Z. Li, Y. Huang, R. Karaman, P.T. Ivanova, H.A. Brown, T. Roddy, and et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis J Clin Invest 122 2012 4130 4144
17. E. Smagris, S. BasuRay, J. Li, Y. Huang, K.M. Lai, J. Gromada, and et al. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis Hepatology 61 2015 108 118
18. J.Y. Huh, G. Panagiotou, V. Mougios, M. Brinkoetter, M.T. Vamvini, B.E. Schneider, and et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise Metabolism 61 2012 1725 1738
19. K. Komolka, E. Albrecht, L. Schering, J. Brenmoehl, A. Hoeflich, and S. Maak Locus characterization and gene expression of bovine FNDC5: Is the myokine irisin relevant in cattle? PLoS One 9 2014 e88060
20. S. Aydin, T. Kuloglu, S. Aydin, M.N. Eren, A. Celik, M. Yilmaz, and et al. Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: Cardiac muscle produces more irisin than skeletal muscle Peptides 52 2014 68 73
21. S. Aydin, T. Kuloglu, S. Aydin, M. Kalayci, M. Yilmaz, T. Cakmak, and et al. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues Peptides 61 2014 130 136
22. J. Lv, Y. Pan, X. Li, D. Cheng, H. Ju, J. Tian, and et al. Study on the distribution and elimination of the new hormone irisin in vivo: New discoveries regarding irisin Horm Metab Res 2015 10.1055/s-0035-1547261
23. D.M. Samy, C.A. Ismail, and R.A. Nassra Circulating irisin concentrations in rat models of thyroid dysfunction - Effect of exercise Metabolism 64 2015 804 813
24. M.J. Park, D.I. Kim, J.H. Choi, Y.R. Heo, and S.H. Park New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro Cell Signal 27 2015 1831 1839
25. S.A. Polyzos, J. Kountouras, A.D. Anastasilakis, E.V. Geladari, and C.S. Mantzoros Irisin in patients with nonalcoholic fatty liver disease Metabolism 63 2014 207 217
26. S.A. Polyzos, J. Kountouras, and C. Zavos Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis J Clin Gastroenterol 44 2010 229 230
27. S.A. Polyzos, J. Kountouras, C. Zavos, and C. Stergiopoulos Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: The two sides of the same coin Med Hypotheses 74 2010 1089 1090
28. S.A. Polyzos, J. Kountouras, and C.S. Mantzoros Leptin in nonalcoholic fatty liver disease: A narrative review Metabolism 64 2015 60 78
29. D. Kraus, Q. Yang, D. Kong, A.S. Banks, L. Zhang, J.T. Rodgers, and et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity Nature 508 2014 258 262
30. H.J. Zhang, X.F. Zhang, Z.M. Ma, L.L. Pan, Z. Chen, H.W. Han, and et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults J Hepatol 59 2013 557 562
31. E.S. Choi, M.K. Kim, M.K. Song, J.M. Kim, E.S. Kim, W.J. Chung, and et al. Association between serum irisin levels and non-alcoholic fatty liver disease in health screen examinees PLoS One 9 2014 e110680
32. K.H. Park, L. Zaichenko, M. Brinkoetter, B. Thakkar, A. Sahin-Efe, K.E. Joung, and et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome J Clin Endocrinol Metab 98 2013 4899 4907
33. B. Yan, X. Shi, H. Zhang, L. Pan, Z. Ma, S. Liu, and et al. Association of serum irisin with metabolic syndrome in obese Chinese adults PLoS One 9 2014 e94235
34. E. Albrecht, F. Norheim, B. Thiede, T. Holen, T. Ohashi, L. Schering, and et al. Irisin - A myth rather than an exercise-inducible myokine Sci Rep 5 2015 8889
35. M.A. Schumacher, N. Chinnam, T. Ohashi, R.S. Shah, and H.P. Erickson The structure of irisin reveals a novel intersubunit beta-sheet fibronectin type III (FNIII) dimer: Implications for receptor activation J Biol Chem 288 2013 33738 33744
36. P. Lee, J.D. Linderman, S. Smith, R.J. Brychta, J. Wang, C. Idelson, and et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans Cell Metab 19 2014 302 309
37. D. Loffler, U. Muller, K. Scheuermann, D. Friebe, J. Gesing, J. Bielitz, and et al. Serum irisin levels are regulated by acute strenuous exercise J Clin Endocrinol Metab 100 2015 1289 1299
38. J.Y. Huh, and C.S. Mantzoros Irisin physiology, oxidative stress, and thyroid dysfunction: What next? Metabolism 64 2015 765 767
39. P.A. Bostrom, J.M. Fernandez-Real, and C. Mantzoros Irisin in humans: Recent advances and questions for future research Metabolism 63 2014 178 180
40. Y. Zhang, R. Li, Y. Meng, S. Li, W. Donelan, Y. Zhao, and et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling Diabetes 63 2014 514 525
41. J.Y. Huh, A. Siopi, V. Mougios, K.H. Park, and C.S. Mantzoros Irisin in response to exercise in humans with and without metabolic syndrome J Clin Endocrinol Metab 100 2015 E453 E457
42. H.Y. Choi, S. Kim, J.W. Park, N.S. Lee, S.Y. Hwang, J.Y. Huh, and et al. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans J Clin Endocrinol Metab 99 2014 2778 2785
43. S. Pekkala, P.K. Wiklund, J.J. Hulmi, J.P. Ahtiainen, M. Horttanainen, E. Pollanen, and et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol 591 2013 5393 5400
44. A.B. Crujeiras, M. Pardo, and F.F. Casanueva Irisin: "Fat" or artefact Clin Endocrinol (Oxf) 82 2015 467 474
45. H.M. Feldmann, V. Golozoubova, B. Cannon, and J. Nedergaard UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality Cell Metab 9 2009 203 209
46. S. Raschke, M. Elsen, H. Gassenhuber, M. Sommerfeld, U. Schwahn, B. Brockmann, and et al. Evidence against a beneficial effect of irisin in humans PLoS One 8 2013 e73680